{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:28:41Z","timestamp":1773685721806,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,8]]},"DOI":"10.7759\/cureus.22025","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T16:53:19Z","timestamp":1644339199000},"source":"Crossref","is-referenced-by-count":1,"title":["Extranodal Diffuse Large B-Cell Lymphoma of Bone and Soft Tissue Presenting With Marked Lymphedema and Hypercalcemia"],"prefix":"10.7759","author":[{"given":"Arafat","family":"Shabbir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arsenije","family":"Kojadinovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaz","family":"Gidfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhjot S","family":"Mundi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton LM","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006, 107:265-76. 10.1182\/blood-2005-06-2508","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2012.12.009","article-title":"Diffuse large B-cell lymphoma","volume":"87","author":"Martelli M","year":"2013","unstructured":"Martelli M, Ferreri AJ, Agostinelli C, Di Rocco A, Pfreundschuh M, Pileri SA. Diffuse large B-cell lymphoma. Crit Rev Oncol Hematol. 2013, 87:146-71. 10.1016\/j.critrevonc.2012.12.009","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz R","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW, et al.. Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med. 2018, 378:1396-407. 10.1056\/NEJMoa1801445","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04749.x","article-title":"Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation - a population-based study of 1575 cases","volume":"124","author":"M\u00f8ller MB","year":"2004","unstructured":"M\u00f8ller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation - a population-based study of 1575 cases. Br J Haematol. 2004, 124:151-9. 10.1046\/j.1365-2141.2003.04749.x","journal-title":"Br J Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0215(19970917)72:6<923::aid-ijc1>3.0.co;2-r","article-title":"The epidemiology of non-Hodgkin's lymphoma: comparison of nodal and extra-nodal sites","volume":"72","author":"Newton R","year":"1997","unstructured":"Newton R, Ferlay J, Beral V, Devesa SS. The epidemiology of non-Hodgkin's lymphoma: comparison of nodal and extra-nodal sites. Int J Cancer. 1997, 72:923-30. 10.1002\/(sici)1097-0215(19970917)72:6&lt;923::aid-ijc1&gt;3.0.co;2-r","journal-title":"Int J Cancer"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12<2311::AID-CNCR13>3.0.CO;2-X","article-title":"The National Cancer Data Base report on non-Hodgkin's lymphoma","volume":"80","author":"Glass AG","year":"1997","unstructured":"Glass AG, Karnell LH, Menck HR. The National Cancer Data Base report on non-Hodgkin's lymphoma. Cancer. 1997, 80:2311-20.","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009608","article-title":"Isolated skeletal muscle recurrence of an originally nodal diffuse large B cell lymphoma: a case report and review of the literature","volume":"97","author":"Spetsieris N","year":"2018","unstructured":"Spetsieris N, Giannakopoulou N, Variami E, et al.. Isolated skeletal muscle recurrence of an originally nodal diffuse large B cell lymphoma: a case report and review of the literature. Medicine (Baltimore). 2018, 97:e9608. 10.1097\/MD.0000000000009608","journal-title":"Medicine (Baltimore)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/32.suppl_2.11","article-title":"Differential effect of glucocorticoids on calcium absorption and bone mass","volume":"32","author":"Gennari C","year":"1993","unstructured":"Gennari C. Differential effect of glucocorticoids on calcium absorption and bone mass. Br J Rheumatol. 1993, 32:11-4. 10.1093\/rheumatology\/32.suppl_2.11","journal-title":"Br J Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S83681","article-title":"Hypercalcemia of malignancy and new treatment options","volume":"11","author":"Sternlicht H","year":"2015","unstructured":"Sternlicht H, Glezerman IG. Hypercalcemia of malignancy and new treatment options. Ther Clin Risk Manag. 2015, 11:1779-88. 10.2147\/TCRM.S83681","journal-title":"Ther Clin Risk Manag"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx635","article-title":"From hepatitis C virus infection to B-cell lymphoma","volume":"29","author":"Couronn\u00e9 L","year":"2018","unstructured":"Couronn\u00e9 L, Bachy E, Roulland S, et al.. From hepatitis C virus infection to B-cell lymphoma. Ann Oncol. 2018, 29:92-100. 10.1093\/annonc\/mdx635","journal-title":"Ann Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20608","article-title":"Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection","volume":"41","author":"Duberg AS","year":"2005","unstructured":"Duberg AS, Nordstr\u00f6m M, T\u00f6rner A, et al.. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology. 2005, 41:652-9. 10.1002\/hep.20608","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1513288","article-title":"Remission of follicular lymphoma after treatment for hepatitis C virus infection","volume":"375","author":"Maciocia N","year":"2016","unstructured":"Maciocia N, O'Brien A, Ardeshna K. Remission of follicular lymphoma after treatment for hepatitis C virus infection. N Engl J Med. 2016, 375:1699-701. 10.1056\/NEJMc1513288","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V91.7.2433","article-title":"Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1\/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas","volume":"91","author":"Ivanovski M","year":"1998","unstructured":"Ivanovski M, Silvestri F, Pozzato G, Anand S, Mazzaro C, Burrone OR, Efremov DG. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1\/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood. 1998, 91:2433-42.","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.12.039","article-title":"Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism","volume":"130","author":"Pal S","year":"2006","unstructured":"Pal S, Sullivan DG, Kim S, et al.. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology. 2006, 130:1107-16. 10.1053\/j.gastro.2005.12.039","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5114\/ceh.2018.78124","article-title":"Antiviral therapy in hepatitis C-infected patients prevents relapse of diffuse large B cell lymphoma","volume":"4","author":"Pellicelli A","year":"2018","unstructured":"Pellicelli A, Giannelli V, Zoli V, Pellicelli V, Zignego AL. Antiviral therapy in hepatitis C-infected patients prevents relapse of diffuse large B cell lymphoma. Clin Exp Hepatol. 2018, 4:197-200. 10.5114\/ceh.2018.78124","journal-title":"Clin Exp Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31110","article-title":"Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients","volume":"142","author":"Hosry J","year":"2018","unstructured":"Hosry J, Miranda RN, Samaniego F, Economides MP, Torres HA. Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients. Int J Cancer. 2018, 142:940-8. 10.1002\/ijc.31110","journal-title":"Int J Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2018.304426","article-title":"Agent Orange during the Vietnam War: the lingering issue of its civilian and military health impact","volume":"108","author":"Stellman JM","year":"2018","unstructured":"Stellman JM, Stellman SD. Agent Orange during the Vietnam War: the lingering issue of its civilian and military health impact. Am J Public Health. 2018, 108:726-8. 10.2105\/AJPH.2018.304426","journal-title":"Am J Public Health"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/nature01537","article-title":"The extent and patterns of usage of Agent Orange and other herbicides in Vietnam","volume":"422","author":"Stellman JM","year":"2003","unstructured":"Stellman JM, Stellman SD, Christian R, Weber T, Tomasallo C. The extent and patterns of usage of Agent Orange and other herbicides in Vietnam. Nature. 2003, 422:681-7. 10.1038\/nature01537","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.7219","article-title":"Dioxin revisited: developments since the 1997 IARC classification of dioxin as a human carcinogen","volume":"112","author":"Steenland K","year":"2004","unstructured":"Steenland K, Bertazzi P, Baccarelli A, Kogevinas M. Dioxin revisited: developments since the 1997 IARC classification of dioxin as a human carcinogen. Environ Health Perspect. 2004, 112:1265-8. 10.1289\/ehp.7219","journal-title":"Environ Health Perspect"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.17226\/25137","article-title":"","author":"National Academies of Sciences","year":"2018","unstructured":"National Academies of Sciences, Engineering, and Medicine. Veterans and Agent Orange: Update 11 (2018). The National Academies Press, Washington, DC; 2018. 10.17226\/25137"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.1990.00390230009002","article-title":"The association of selected cancers with service in the US military in Vietnam","volume":"150","author":"Suskind R","year":"1990","unstructured":"Suskind R. The association of selected cancers with service in the US military in Vietnam. Arch Intern Med. 1990, 150:2449-50.","journal-title":"Arch Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/82.6.486","article-title":"Exposure to dioxins as a risk factor for soft tissue sarcoma: a population-based case-control study","volume":"82","author":"Eriksson M","year":"1990","unstructured":"Eriksson M, Hardell L, Adami HO. Exposure to dioxins as a risk factor for soft tissue sarcoma: a population-based case-control study. J Natl Cancer Inst. 1990, 82:486-90. 10.1093\/jnci\/82.6.486","journal-title":"J Natl Cancer Inst"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199101243240402","article-title":"Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"324","author":"Fingerhut MA","year":"1991","unstructured":"Fingerhut MA, Halperin WE, Marlow DA, et al.. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N Engl J Med. 1991, 324:212-8. 10.1056\/NEJM199101243240402","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.106-1533419","article-title":"Exposure to Agent Orange and occurrence of soft-tissue sarcomas or non-Hodgkin lymphomas: an ongoing study in Vietnam","volume":"106","author":"Kram\u00e1rov\u00e1 E","year":"1998","unstructured":"Kram\u00e1rov\u00e1 E, Kogevinas M, Anh CT, Cau HD, Dai LC, Stellman SD, Parkin DM. Exposure to Agent Orange and occurrence of soft-tissue sarcomas or non-Hodgkin lymphomas: an ongoing study in Vietnam. Environ Health Perspect. 1998, 106:671-8. 10.1289\/ehp.106-1533419","journal-title":"Environ Health Perspect"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/78304-extranodal-diffuse-large-b-cell-lymphoma-of-bone-and-soft-tissue-presenting-with-marked-lymphedema-and-hypercalcemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:33Z","timestamp":1707507873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/78304-extranodal-diffuse-large-b-cell-lymphoma-of-bone-and-soft-tissue-presenting-with-marked-lymphedema-and-hypercalcemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.22025","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,8]]}}}